000 01324 a2200373 4500
005 20250515114624.0
264 0 _c20080812
008 200808s 0 0 eng d
022 _a1543-5946
024 7 _a10.1016/j.amjopharm.2008.03.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbdelhafiz, Ahmed H
245 0 0 _aRisk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
_h[electronic resource]
260 _bThe American journal of geriatric pharmacotherapy
_cMar 2008
300 _a1-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHemorrhage
_xetiology
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRisk Factors
650 0 4 _aWarfarin
_xadverse effects
700 1 _aWheeldon, Nigel M
773 0 _tThe American journal of geriatric pharmacotherapy
_gvol. 6
_gno. 1
_gp. 1-11
856 4 0 _uhttps://doi.org/10.1016/j.amjopharm.2008.03.005
_zAvailable from publisher's website
999 _c17895046
_d17895046